Profound Medical - רווח נקי למניה בארבעת הרבעונים האחרונים PROF

Profound Medical Corp. (PROF) is strengthening its position by implementing minimally invasive MRI-guided therapies and securing insurance codes in the US. However, the pace of expansion is hindered by physician training inertia and competition. Market price fluctuations on GURU.Markets show an EPS of 30.30. The business relies on the TULSA-PRO system, which enables the efficient destruction of prostate tumors using ultrasound, providing the company with significant pricing power.

Profound Medical Corp. is optimizing costs by outsourcing equipment production and cloud services to third-party contractors. This indicator measures the annual change in net income per share over a rolling twelve-month period. This allows the investor to assess the efficiency of the business model's scaling and the actual return on equity. When analyzing the historical annual dynamics of EPS TTM, one should consider the impact of high interest rates on the company's financial stability.